title: A hyperosmolar-colloidal additive to the CPB-priming solution reduces fluid load and fluid extravasation during tepid CPB.
abstract: Cardiopulmonary bypass(CPB) is associated with fluid overload. We hypothesized that fluid gain during CPB could be reduced by substituting parts of a crystalloid prime with 7.2% hypertonic saline and 6% poly (O-2-hydroxyethyl) starch solution (HyperHaes). 14 animals were randomized to a control group (Group C) or to Group H. CPB-prime in Group C was Ringer's solution. In group H, 4 ml/kg of Ringer's solution was replaced by the hypertonic saline/hydroxyethyl starch solution. After 60 min stabilization, CPB was initiated and continued for 120 min. All animals were allowed drifting of normal temperature (39.0 degrees C) to about 35.0 degrees C. Fluid was added to the CPB circuit as needed to maintain a 300-ml level in the venous reservoir. Blood chemistry, hemodynamic parameters, fluid balance, plasma volume, fluid extravasation rate (FER), tissue water content and acid-base parameters were measured/calculated. Total fluid need during 120 min CPB was reduced by 60% when hypertonic saline/hydroxyethyl starch solution was added to the CPB prime (p < 0.01). The reduction was related to a lowered FER. The effect was most pronounced during the first 30 min on CPB, with 0.6 (0.43) (Group H) compared with 1.5 (0.40) ml/kg/min (Group C) (p < 0.01). Hemodynamics and laboratory parameters were similar in both groups. Serum concentrations of sodium and chloride increased to maximum levels of 148 (1.5) and 112 (1.6) mmol/l in Group H. To conclude: addition of 7.2% hypertonic saline and 6% poly (O-2-hydroxyethyl) starch solution to crystalloid CPB prime reduces fluid needs and FER during tepid CPB.
authors.affiliation: Section for Cardiothoracic Surgery, Department of Heart Disease, Haukeland University Hospital, N-5021 Bergen, Norway.
authors.forename: V
authors.initials: V
authors.lastname: Kvalheim
authors.forename: M
authors.initials: M
authors.lastname: Farstad
authors.forename: O
authors.initials: O
authors.lastname: Haugen
authors.forename: H
authors.initials: H
authors.lastname: Brekke
authors.forename: A
authors.initials: A
authors.lastname: Mongstad
authors.forename: E
authors.initials: E
authors.lastname: Nygreen
authors.forename: P
authors.initials: P
authors.lastname: Husby
mesh_terms: D000818:Animals; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass; D000077324:Crystalloid Solutions; D006438:Hemodilution; D006439:Hemodynamics; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D009994:Osmolar Concentration; D010953:Plasma Volume; D011897:Random Allocation; D000077331:Ringer's Solution; D012462:Saline Solution, Hypertonic; D034421:Sus scrofa; D014882:Water-Electrolyte Balance
chemical_list: D000077324:Crystalloid Solutions; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D012462:Saline Solution, Hypertonic; D000077331:Ringer's Solution